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Abstract
Background: Squamous cell carcinoma mainly afflicts patients older than 40 years of age however, few cases are
seen in younger patients. The aim of this study therefore was to determine the incidence of squamous cell
carcinoma of the oral cavity and oropharynx in patients less than 40 years of age with a view to assessing the
prognosis over a period of time.
Methods: This was a 20 years retrospective review of patients who were histologically diagnosed with squamous
cell carcinoma of the oral cavity and the oropharynx at the Department of Cranio-Maxillo-Facial Surgery of the
Hannover Medical School, Germany and had not received treatment anywhere else. Records of these patients were
analysed for age and sex distribution, tumour staging and differentiation, location, treatment given, recurrences and
metastasis, time between diagnosis and death or last contact with patient, and possible cause of death.
Comparisons were also made with patients older than 40 years of age.
Results and discussion: A total of 977 patients treated for squamous cell carcinoma of the oral cavity and the
oropharynx in the 20-year period of this study were included. Thirty eight (3.9 %) of the overall patient population
were under 40 years of age. Among these, 30 (78.9%) were males and 8 (21.1%) were females. The incidence was
highest in the 30–39 year age group accounting for 31 (81.6%) of the 38 patients. The moderately differentiated
carcinoma was commonest (24; 63.2%). The floor of the mouth had the highest number of tumours (15; 39.5%), but
none was seen in the oropharynx. Surgery alone was the main stay of treatment given to 26 (68.4%) patients. At
the end of the study period, 13 (34.2%) patients had died of the tumour and the 5-year survival rate was 66.2%. In
the older patient group (>40 years), 42.7% died from the tumour and the 5-year survival rate was 57.6%.
Conclusion: The results from the present study showed that young adults may have a better prognosis especially
in terms of long term overall survival from oral and oropharyngeal carcinoma.
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Background
Squamous cell carcinoma (SCC) in the head and neck
region occurs primarily in the oral cavity and orophar-
ynx and is generally regarded as a disease of the eld-
erly [1]. Majority are seen in patients over the age of
40 years, whereas the tumour remains very uncommon
among young adults [2]. A review of literature revealed
that the incidence of SCC of the oral cavity (OC) and the
oropharynx (OP) in young adults ranges between 1-
6% [3-5] with the tongue frequently reported as the
commonest location for this tumour[4].
It is logical to assume that the fewer cases of this
tumour in young patients are due to the considerable
shorter exposure period to the risk factors of alcohol
and tobacco when compared to the elderly patients [3].
However, some cases have been reported in non-smoking,
non-alcohol drinking youths which then raises the
question as to other possible aetiological factors in this
young population [6,7].
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prognosis of SCC of the OC and OP in young adults.
While some claim that there is no difference in progno-
sis between the disease in the elderly and the young
adult patients [8,9], others report a worse prognosis in
the young adults and therefore recommend a more ag-
gressive management regime for this group [10].
We therefore present our experience in the manage-
ment of patients with SCC of the OC and the OP over a
20-year period with particular attention to patients less
than 40 years of age and also making comparisons to
older patients above 40 years.Table 1 Age and gender distribution of the general
patients population (n =977)






15-19 1 0 1 0,1
20-29 6 4 2 0,6
30-39 31 26 5 3,2
40-49 222 182 40 22,7
50-59 358 289 69 36,6
60-69 211 154 57 21,6
70-79 104 57 47 10,6
80-89 43 20 23 4,4
≥ 90 1 1 0 0,1
Total 977 733 244 100
Average age in years 57,6 56,3 61,4Methods
The records of patients who were histologically diagnosed
with squamous cell carcinoma of the oral cavity and the
oropharynx at the Department of Cranio-Maxillo-Facial
Surgery of the Hannover Medical School, Germany be-
tween 1980 and 1999 were retrospectively reviewed.
Patients included in this study must not have been treated
for their cancer anywhere else.
The data extracted were analysed for demographic in-
formation, tumour differentiation, size, location, treat-
ment given, recurrences, second primaries and
metastasis, time between diagnosis and death or last
contact with patient, and possible cause of death.
Patients were divided into 9 groups according to their
ages at diagnosis: Group 1 (10–19 years); group 2 (20–
29 years); group 3 (30–39 years); group 4 (40–49 years);
group 5 (50–59 years); group 6 (60–69 years); group 7
(70–79 years); group 8 (80–89 years); and group 9
(90 years and above). TNM system was used for the
tumour staging whereas the location was categorised
using the International Classification of Diseases of the
WHO into:
– ICD-141 (Tongue),
– ICD-143-143.13 (Mandibular and Maxillary
mucosa),
– ICD-144-144.9 (Floor of the mouth),
– ICD-145-145.9 (Other parts of the mouth),
– ICD-146-146.2 (Tonsillar region) and
– ICD-146.6-146.9 (Oropharynx).
Treatment given to the patients was divided into sur-
gery, radiotherapy, chemotherapy, hormone therapy, a
combination of these or none. Statistical analysis was
done using SPSS for windows (version 9.0) and the cal-
culation of survival rates for the groups less than
40 years and those above 40 was done using the
Kaplan-Meier estimates. Log-rank test was the statistical
test used and a result is considered significant when
p is< 0.05.Results
Demographics
A total of 977 previously untreated patients, with histo-
logically diagnosed SCC of the OC and the OP were
seen within the period under review in this study. Male
patients were 733 (75%), and female patients 244(25%)
and the mean age for the general patients population
was 57.6.
Thirty eight (3.9%) of the overall patient population
were under 40 years of age, and 30 (78.9%) of them were
males and 8 (21.1%) female. The youngest male patient
at diagnosis was 24 years old and the youngest female
patient 19 years. (Table 1)Tumour differentiation grading
Among the patients less than 40 years of age, 24 (63.2%)
had moderately differentiated SCC, 7(18.4%) had well
differentiated tumour and 5 (13.2%) had poorly differen-
tiated tumour. Information regarding histological differ-
entiation could not be found for 2 patients in this age
group. Tables 2 and 3 show the histological differenti-
ation in the general population and in those less than
40 years respectively.Tumour location
The floor of the mouth was the commonest site of
tumour occurrence both in the general population and
in patients less than 40 years of age. This accounted for
42.2% in the general patient population and 39.5% in the
group less than 40 years. Only in 1.3% of the overall pa-
tient population was the tumour located in the oro-
phaynx and none was found in the oropharynx of the
young patient group. (Tables 4 and 5)
Table 2 Histological grade of differentiation (all patients)
Histological Differentiation
n %
1 well differentiated 141 14,4%
2 moderately differentiated 672 68,8%
3 poorly differentiated 105 10,7%











Floor of the mouth 412 42,2
Other parts of the mouth 152 15,6
Mandibular and Maxillary mucosa 131 13,4
Tonsillar region 49 5,0
Oropharynx 13 1,3
Total 977 100
Table 5 Tumour location in patients younger than
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As at the time of diagnosis, T1 tumours occurred most
frequently, accounting for 32.0% of the whole patient
population. Males were seen to have larger tumours at
presentation than females with a p-value of 0.005 which
is highly significant. However, there was no significant
difference between the groups of patients less than
40 years and those older than 40 years. (Figures 1 and 2)
Treatment
Information regarding treatment could not be found for
21 (2.1%) patients and 4 (0.4%) patients received no
treatment at all. However, surgery was the only treat-
ment given to 67.5% of the general population, while
14.8% had surgery in combination with chemotherapy or
radiotherapy. Only 1.5% had radiotherapy alone, 1.3%
had chemotherapy and 0.1% had hormone therapy. In
the group of patients less than 40 years, surgery alone
was the treatment in 26 (68.4%) patients, surgery in
combination with chemotherapy and/or radiotherapy
was used for 9 (23.7%) patients and 3 (7.9%) patients
had only chemotherapy plus radiotherapy.
Second primaries, recurrences and metastasis
Secondary tumours developed in 112 patients (11.5%)
during the study period, 190 patients (19.4%) had recur-
rences, 388 patients (39.7%) showed signs of clinical me-
tastasis and in 54 other patients (5.5%), there was distant
metastasis.Table 3 Histological grade of differentiation (patients
younger than 40 years)
Histological Differentiation
n %
1 well differentiated 7 18,4%
2 moderately differentiated 24 63,2%
3 poorly differentiated 5 13,2%
Value 36 94,7%
Missing 2 5,3%
Total 38 100%Local recurrence-free survival
Comparison of the local recurrence-free survival for the
group less than 40 years and the group above 40 years
using the log-rank test yielded no significant result
(p = 0.1209). (Figure 3)Cause of death and survival analysis
By the end of the study period, 418 patients (42.8%) had
died of the tumour, while 559 patients (57.2%) were still
alive. A further breakdown revealed that the overall 5-
year survival rate was 57.9%, 10-year survival rate was
46.9%, and 15-year survival was 30.9%. (Figure 4)
Among the 38 patients less than 40 years of age, 13
patients (34.2%) had died of the tumour at the end of the
study period, while the 25 other patients (65.8%) were
still alive or their death was not caused by the tumour.
The 5-year survival rate for this group was 66.2%.
(Figure 5)
Furthermore, for the group 40 years and older, 401
(42.7%) patients had died of the tumour at the end of
the study period, with a 5-year survival rate of 57.6%.
(Figure 5)Discussion
Many conflicting results have been reported regarding
whether age at diagnosis influences prognosis of squa-








Tongue 13 9 4 34,2
Floor of the mouth 15 13 2 39,5
Other parts of the mouth 3 2 1 7,9
Mandibular and
Maxillary mucosa
4 3 1 10,5
Tonsillar region 3 3 0 7,9
Oropharynx 0 0 0 0





























Figure 1 T-stages (based on T1-T4) and sex of the patients (n = 977). A comparison of men versus women using the log-rank test showed a
highly significant result (p = 0.005).
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ence in the management of these young patients over a
20-year period with comparison also to the older
patients’ population seen within the same study period.
An incidence of 3.9% of SCC of the OC and OP in
patients less than 40 years of age found in this study
compares favourably with other similar reports, thus
confirming the rarity of this tumour in young patients
[13,14]. Hart et al. [1] however reported an incidence of
15.75% which is significantly higher than the results
found in other literature. The authors noted that their
small sample size and the overwhelming young popula-
tion in attendance to their hospital may have contributed
to the high incidence rate.
There is a general agreement in the literature of a
higher male preponderance of SCC of the OC and OP in
young patients [4,15-18]. A male to female ratio of 3.8:1























Figure 2 T-stages (based on T1-T4) by age groups of patients (n = 977
than 40 years shows no significant result using the log-rank test.a bit higher than a few other reports which gave the gen-
der ratio to be 1.6:1 [15], 1.7:1 [4], 1.9:1 [16], and 2.3:1
[17]. Our result on the other hand is far less than 6.7:1
male to female ratio reported by Cusumano and Persky
[18]. Geographic locations and social lifestyles among
different world populations might have accounted for
these variations.
The tongue is reported as the most common location
for head and neck SCC in the young adults [1,2,4,19].
This differs from the findings from the present study
in which the tongue is second only to floor of the
mouth as the commonest location. However, consider-
ing women in this young age group alone, the tongue
was by far the preferred site accounting for 50% of the
tumour location. This agrees with the findings of Patel
et al. [7] who reported an increasing incidence of oral
tongue SCC among young white women. Significantly,





). A comparison of the patients less than 40 years with those older
Local recurrence-free survival time in years
P=0.1209
Figure 3 Graphical representation of the local recurrence-free survival time, of the 2 age groups, with the help of the product-limit
method of Kaplan-Meier.
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1.3% of the tumour location in the general study
population.
Oral cavity and oropharyngeal SCC in the young
patients has been linked with history of exposure to
human papilloma virus (HPV), herpes simplex virus
(HSV), human immunodeficiency virus (HIV), and some
other viral infective diseases, although their causative
role remains to be established [6,19,20]. The fact that
even when these young patients indulge in known risk
factors of alcohol and smoking, it is for considerably
shorter periods compared to the adult counterparts as to
induce oral carcinogenesis [3,19] leaves room for further
search as to other responsible aetiological factors. We
cannot however draw any conclusions from our study as
regards risk factor-tumour location association since our
retrospective review did not include any of the viral risk
factors.c
Survival 
Figure 4 Graphical representation of the survival probability of the
Kaplan-Meier.As regards the tumour staging and grading, there was
no significant difference between the groups of patients
less than 40 years and those above 40 using the log-rank
test (tables 2 and 3, Figure 2). T1 and T2 tumours were
the predominant stages for both groups and majority
were moderately differentiated tumours. Mallet et al. [2]
in a multi-centre analysis of head and neck SCC in
young patients in France also reported that most of their
patients presented with T1 and T2 tumours. But of sig-
nificance in our report however is the result showing
that males presented with larger tumours than females
at diagnosis (p = 0.005). This underscores the fact that
women generally take better care of their bodies than
men and visit the hospitals for check-ups more fre-
quently than men do [21].
There is a general claim by some authors that patients
in the younger age group have a more aggressive disease
with a higher incidence of local recurrence or regionaltime in years
entire group, with the help the product-limit method of
Survival time in years
P=0.0224
Figure 5 Graphical representation of the survival probability of the 2 age groups, with the help of the product-limit method of
Kaplan-Meier.
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older patients [10,22]. Our comparison of the local re-
currence-free survival for the group less than 40 years
and the group above 40 years using the log-rank test
yielded no significant result (p = 0.1209). The only
observed discrepancy in this regard was that the young
patients did not show sign of recurrences after 2 years
whereas in the older patients, there were recurrences
even after 10 years following treatment (Figure 3). This
may be expected because drinking and smoking habits
are more prevalent in the older age group and hence can
result in a significantly increased risk of second and sub-
sequent smoking-related cancers [23].
Our records show that at the end of the study period,
13 (34.2%) out of the 38 patients in the young group had
died of the tumour and 401 (42.7%) out of 927 in older
patients’ group had also died from the tumour. The
overall 5-year survival was found to be 66.2% and 57.2%
in patients less than 40 years and those above 40 years
respectively. This was found to be statistically significant
when compared using the log-rank test (p = 0.0224). Be-
fore we jump to the conclusion that younger patients
have a better prognosis based on the above findings, we
should remember the effect of comorbidities on head
and neck cancer patients which affects the older patients
more [24]. Patients with higher comorbid burden are
likely to die earlier due to concurrent illness compared
to those who are otherwise free of diseases apart from
head and neck cancer [25]. This will therefore affect the
overall survival of the patient [26].
Conclusions
Our review revealed that patients less than 40 years with
SCC of OC and OP have a comparable histopathologic
features and clinical course with those older than 40 years
of age. Their local recurrence-free survival also shows nostatistical significant difference, however, the 5-year over-
all survival is better in the young adult group than in the
older patients’ group. This goes to show that there may
not be need for a more aggressive treatment for young
patients with SCC of the OC and OP as is being advo-
cated in some literature.
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